These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8866465)

  • 1. Metabolism and pharmacokinetics of albendazole after oral administration to chickens.
    Csikó GY; Banhidi GY; Semjén G; Laczay P; Ványine Sándor G; Lehel J; Fekete J
    J Vet Pharmacol Ther; 1996 Aug; 19(4):322-5. PubMed ID: 8866465
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative disposition kinetics of albendazole in sheep following oral and intraruminal administration.
    Swarnkar CP; Sanyal PK; Singh D; Khan FA; Bhagwan PS
    Vet Res Commun; 1998 Dec; 22(8):545-51. PubMed ID: 10066128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
    Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
    Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition kinetics of albendazole and metabolites in laying hens.
    Bistoletti M; Alvarez L; Lanusse C; Moreno L
    J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ricobendazole in calves.
    Formentini EA; Mestorino ON; Mariño EL; Errecalde JO
    J Vet Pharmacol Ther; 2001 Jun; 24(3):199-202. PubMed ID: 11442798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2002 Dec; 23(9):379-83. PubMed ID: 12469331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.
    Li Z; Chen C; Ai D; Wang C; Li J; Qi Y; Yi W; Shen H; Cao J
    Environ Toxicol Pharmacol; 2012 Mar; 33(2):197-204. PubMed ID: 22227164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.
    Capece BP; Castells G; Pérez F; Arboix M; Cristòfol C
    Vet Res Commun; 2000 Jul; 24(5):339-48. PubMed ID: 10868551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of albendazole and its main metabolites in plasma.
    Garcia JJ; Bolás-Fernández F; Torrado JJ
    J Chromatogr B Biomed Sci Appl; 1999 Feb; 723(1-2):265-71. PubMed ID: 10080654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The disposition kinetics of albendazole following the administration of single and divided doses to cattle and buffalo.
    Sanyal PK
    Vet Res Commun; 1998 Feb; 22(2):87-96. PubMed ID: 9563167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and residue depletion of albendazole and its metabolites in rainbow trout, tilapia and Atlantic salmon after oral administration.
    Shaikh B; Rummel N; Gieseker C; Serfling S; Reimschuessel R
    J Vet Pharmacol Ther; 2003 Dec; 26(6):421-7. PubMed ID: 14962053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of netobimin metabolites in pregnant ewes.
    Cristòfol C; Franquelo C; Navarro M; Carretero A; Ruberte J; Arboix M
    Res Vet Sci; 1997; 62(2):117-20. PubMed ID: 9243708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and depletion of albendazole in the muscle tissue of channel catfish following oral treatment.
    Shaikh B; Rummel N; Gieseker C; Reimschuessel R
    J Vet Pharmacol Ther; 2006 Dec; 29(6):525-30. PubMed ID: 17083456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dose increase or cimetidine co-administration on albendazole bioavailability.
    Schipper HG; Koopmans RP; Nagy J; Butter JJ; Kager PA; Van Boxtel CJ
    Am J Trop Med Hyg; 2000; 63(5-6):270-3. PubMed ID: 11421376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of different benzimidazole volume-dose formulations in sheep.
    Benchaoui HA; Futter IJ; Holton LL; Gettinby G; McKellar QA
    Vet Rec; 1995 Aug; 137(7):171-2. PubMed ID: 8553527
    [No Abstract]   [Full Text] [Related]  

  • 16. Time dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidic matrix of albendazole: an alternative for systemic infections.
    Savio E; Domínguez L; Malanga A; Quevedo D; Saldaña J; Camarote C; Ochoa A; Fagiolino P
    Boll Chim Farm; 1998 Oct; 137(9):345-9. PubMed ID: 9859596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
    Lanchote VL; Garcia FS; Dreossi SA; Takayanagui OM
    Ther Drug Monit; 2002 Jun; 24(3):338-45. PubMed ID: 12021623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet-induced modulation of pharmacokinetics of albendazole in Sahiwal cattle.
    Sanyal PK; Rawte D; Kerketta AE; Kumbhakar NK; Kumar D; Pal S; Baghel KR; Bisen S
    J Helminthol; 2016 Sep; 90(5):555-60. PubMed ID: 26306773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep.
    Formentini EA; Mestorino N; Errecalde JO
    Vet Res Commun; 2005 Oct; 29(7):595-608. PubMed ID: 16142607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.